Approval · Notice of Compliance 3328 · 1997
SUPREFACT: Notice of Compliance 3328
Issued September 30, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3328
- Date
- September 30, 1997
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Providing for the endocrine treatment of patients with endometriosis
- Therapeutic class
- Luteinizing hormone-releasing hormone (lh-rh) analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPREFACT | Not yet assigned | — |
Medicinal ingredients
- BUSERELIN ACETATE 1 MG per ML